CD36 and breast carcinoma: Furthermore, Kaplan-Meier analysis revealed that patients with FATP1 or CD36 overexpression in breast cancer tissue had a poorer survival time than patients with those protein underexpression (Figure 1B, P < 0.01 and P = 0.019, log-rank test).